Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide-Reference-Cited by-同舟云学术

Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by Glucosylceramide

Published:2018-01 Issue:1 Volume:97 Page:92-107.e10
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Zunke Friederike,Moise Alexandra C.,Belur Nandkishore R.,Gelyana Eilrayna,Stojkovska Iva,Dzaferbegovic Haris,Toker Nicholas J.,Jeon Sohee,Fredriksen Kristina,Mazzulli Joseph R.

Funder

Medical University of South Carolina

National Institute of Neurological Disorders and Stroke

Northwestern PDMD Advisory Council

Michael J. Fox Foundation

Human Embryonic and Induced Pluripotent Stem Cell Facility at Northwestern University

NIH

Publisher

Elsevier BV

Subject

General Neuroscience

Reference57 articles.

1. Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations;Alcalay;Brain,2015

2. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies;Baba;Am. J. Pathol.,1998

3. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation;Bartels;Nature,2011

4. Non-genetic propagation of strain-specific properties of scrapie prion protein;Bessen;Nature,1995

5. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS);Bielawski;Adv. Exp. Med. Biol.,2010

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease;Translational Neurodegeneration;2024-09-12

2. Lysosome quality control in health and neurodegenerative diseases;Cellular & Molecular Biology Letters;2024-09-05

3. Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies;Cellular and Molecular Life Sciences;2024-09-03

4. Role of Lipids in the Pathogenesis of Parkinson’s Disease;International Journal of Molecular Sciences;2024-08-16

5. GBA1MUTATIONS ALTER THE PHENOTYPE AND BEHAVIOUR OF DOPAMINERGIC NEURONS IN PARKINSON’S DISEASE, INFLUENCINGVGLUT2ANDCRYABEXPRESSION;2024-08-07